Issue 2/2022
Content (8 Articles)
Efficacy and Costs of Three Pharmacotherapies for Patent Ductus Arteriosus Closure in Premature Infants
Ramesh Vidavalur
Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients
Stefania Costi, Teresa Giani, Francesco Orsini, Rolando Cimaz
Drug Treatment of Heart Failure in Children: Gaps and Opportunities
Molly Weisert, Jennifer A. Su, Jondavid Menteer, Robert E. Shaddy, Paul F. Kantor
Safety of Ferric Carboxymaltose in Children: Report of a Case Series from Greece and Review of the Literature
Paraskevi Panagopoulou, Sonia Alexiadou, Maria Ntoumpara, Anna Papazoglou, Alexandros Makis, Athanasios Tragiannidis, Maria Fotoulaki, Elpis Mantadakis
Acute Tolerability of Methylphenidate in Treatment-Naïve Children with ADHD: An Analysis of Naturalistically Collected Data from Clinical Practice
Gabriele Masi, Chiara Pfanner, Francesca Liboni, Francesca Lenzi, Arianna Villafranca, Giulia D’Acunto, Pamela Fantozzi, Francesca Falcone, Valerio Simonelli, Pietro Muratori, Valentina Levantini, Irene Favole, Federico Amianto, Chiara Davico, Benedetto Vitiello
Effect of Mirtazapine on Nausea in Children with Functional Nausea and Functional Dyspepsia Postprandial Distress Syndrome
Ivonne M. Iglesias-Escabi, David Kleesattel, Lee S. McDaniel, Erin Reuther, Colleen LeBlanc, Paul E. Hyman, Neha R. Santucci
Population Pharmacokinetics of Moxifloxacin in Children
Rachel G. Greenberg, Cornelia B. Landersdorfer, Nazario Rivera-Chaparro, Melissa Harward, Thomas Conrad, Aya Nakamura, Carl M. Kirkpatrick, Kenan Gu, Varduhi Ghazaryhan, Blaire Osborn, Emmanuel B. Walter
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years
Thomas A. Luger, Adelaide A. Hebert, Andrea L. Zaenglein, Jonathan I. Silverberg, Huaming Tan, William C. Ports, Michael A. Zielinski